Brief: Salarius Pharmaceuticals Completes SP-3164 Pre-IND Meeting Process With FDA

Decoy Therapeutics

11/05/2022 21:52

May 11 (Reuters) - Salarius Pharmaceuticals Inc  SLRX.O :
    * SALARIUS PHARMACEUTICALS COMPLETES SP-3164
PRE-INVESTIGATIONAL
NEW DRUG MEETING PROCESS WITH THE U.S. FOOD AND DRUG
ADMINISTRATION
    * SALARIUS PHARMACEUTICALS - PLANNING TO SUBMIT AN IND IN
2023
AND, UPON RECEIVING IND ACTIVATION FROM FDA, INITIATE FIRST
CLINICAL TRIAL THAT SAME YEAR

Source text for Eikon:  ID:nGNX6bHDLk 
Further company coverage:  SLRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))